3.60

6.19% 0.21

Pre-market: 3.60

Quanterix Corp (QTRX)

Overview News Price History Option Chain Financials Discussions Forecast

Quanterix Corp stock is traded at $3.60, with a volume of 1.12M. It is up +6.19% in the last 24 hours and down -23.73% over the past month. Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Previous Close:

$3.39

Open:

$3.44

24h Volume:

1.12M

Relative Volume:

1.44

Market Cap:

$168.98M

Revenue:

$138.90M

Net Income/Loss:

$-107.15M

P/E Ratio:

-1.4268

EPS:

-2.5232

Net Cash Flow:

$-79.85M

1W Performance:

+2.86%

1M Performance:

-23.73%

6M Performance:

-37.72%

1Y Performance:

-32.84%

1-Day Range:

$3.44

$3.705

1-Week Range:

$3.235

$3.705

52-Week Range:

$3.235

$8.77

Quanterix Corp Stock (QTRX) Company Profile

Name

Quanterix Corp

Sector

Healthcare (1112)

Industry

Medical Devices (143)

Phone

617-301-9400

Address

900 MIDDLESEX TURNPIKE, BILLERICA, MA

Employee

450

Twitter

@QuanterixSimoa

Next Earnings Date

2025-03-17

Latest SEC Filings

QTRX's Discussions on Twitter

Compare QTRX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
QTRX Quanterix Corp	3.60	159.13M	138.90M	-107.15M	-79.85M	-2.5232
ABT Abbott Laboratories	101.56	175.59B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	341.24	132.47B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.10	113.14B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	64.61	94.85B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	78.20	45.09B	6.07B	1.06B	1.34B	1.8063

Quanterix Corp Stock (QTRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-11-25	Downgrade	Canaccord Genuity	Buy → Hold
Feb-01-24	Initiated	Scotiabank	Sector Outperform
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform
May-23-23	Upgrade	Goldman	Neutral → Buy
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Mar-02-22	Upgrade	Goldman	Sell → Neutral
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell

View All

Quanterix Corp Stock (QTRX) Latest News

Apr 15, 2026

Quanterix (QTRX) to Launch Content Innovation Engine at AACR Ann - GuruFocus

Apr 15, 2026

Quanterix to showcase cancer research tools at AACR meeting - Investing.com

Apr 15, 2026

New Quanterix platform is built to move cancer biology toward the clinic - Stock Titan

Apr 15, 2026

Apr 07, 2026

Quanterix (QTRX) Executive Chair receives 6,178-share stock grant - Stock Titan

Apr 07, 2026

Quanterix (QTRX) director awarded 4,310 shares for board service - Stock Titan

Apr 07, 2026

Apr 02, 2026

Quanterix (QTRX) COO gains stock via RSU vesting with tax withholding - Stock Titan

Apr 02, 2026

Apr 01, 2026

Quanterix Corp Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - Mint

Apr 01, 2026

Mar 30, 2026